Analyst
Perputee
Equibles does not estimate personal net worth.
Neelam is recorded as Analyst at Perputee. Neelam has spoken on 1 earnings call across 1 company, most recently for Jagsonpal Pharmaceuticals Limited on July 30, 2026. The companies whose calls Neelam spoke on are classified in the Healthcare sector.
“My first question is on the Equitas acquisition. So, could you help us understand what is the current product profile, what are the key therapies, leading products, and the mix between branded products and institutional tenders?”
Perputee
Analyst
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Jagsonpal Pharmaceuticals Limited
